Agilent In Agreement With Agendia For Cancer Diagnostics
Bio Spectrum|July 2017

Agilent Technologies Inc. and Agendia, Inc. have jointly announced an agreement to expand their relationship to include the development of an RNA Seq kit version of Agendia’s currently marketed Mamma Print and Blueprint tests.

Agilent In Agreement With Agendia For Cancer Diagnostics

Agendia’s Mamma Print test provides High-Risk or Low-Risk test results to assess the risk of distant metastasis within five years, in breast cancer patients with Stage I or Stage II disease. Agendia’s Blueprint test builds on the foundational prognostic precision of Mamma Print, to classify the breast cancer into one of four molecular sub types. These results help to predict clinical outcomes in women with early-stage breast cancer.

هذه القصة مأخوذة من طبعة July 2017 من Bio Spectrum.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة July 2017 من Bio Spectrum.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BIO SPECTRUM مشاهدة الكل
Early Diabetic Retinopathy Detection Remains a Challenge
Bio Spectrum

Early Diabetic Retinopathy Detection Remains a Challenge

The Vitreo Retinal Society of India (VRSI) and the Research Society for the Study of Diabetes in India (RSSDI) have formulated a first-of-its kind diabetic retinopathy (DR) screening guideline to help physicians and diabetologists in India educate their patients about DR.

time-read
2 mins  |
BioSpectrum India Nov 2024
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
Bio Spectrum

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum India Nov 2024
Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology
Bio Spectrum

Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology

Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.

time-read
1 min  |
BioSpectrum India Nov 2024
Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis
Bio Spectrum

Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis

Thermo Fisher Scientific Inc. has launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).

time-read
1 min  |
BioSpectrum India Nov 2024
Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Bio Spectrum

Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras identifies enhanced drug delivery method for eye treatments
Bio Spectrum

IIT Madras identifies enhanced drug delivery method for eye treatments

Researchers at the Indian Institute of Technology Madras (IIT-M) have demonstrated how drugs injected in the human eye can be better delivered to the target region through ‘convection caused by mild laser heating’.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras develops indigenous POCUS scanner for sports injury diagnosis
Bio Spectrum

IIT Madras develops indigenous POCUS scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-Care-Ultrasound (POCUS) Scanner for sports injury diagnosis and management.

time-read
1 min  |
BioSpectrum India Nov 2024
Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla
Bio Spectrum

Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla

Practo has appointed two new directors to its board: TVG Krishnamurthy and Dr Alexander Kuruvilla.

time-read
1 min  |
BioSpectrum India Nov 2024
Dr R N Gupta steps in as National President of Indian Pharmaceutical Association
Bio Spectrum

Dr R N Gupta steps in as National President of Indian Pharmaceutical Association

Dr R N Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA), the oldest and largest association of pharmaceutical professionals in the country, for the term 2024 - 2026 (October 1, 2024 - September 30, 2026).

time-read
1 min  |
BioSpectrum India Nov 2024
QR678 brings medtech leader Sridhar Ranganathan to advisory board
Bio Spectrum

QR678 brings medtech leader Sridhar Ranganathan to advisory board

QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.

time-read
1 min  |
BioSpectrum India Nov 2024